Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients

    NEXT STORY
    Global Infectious Disease Diagnostics Market (2018 to 2027) – Featuring Abbott Diagnostic, Alere & Beckman Coulter Among Others
    PREV STORY
    SpringWorks Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Advanced Accelerator Applications Announces Presentation of Quality of Life Findings from NETTER-1 Phase III Study at ENETS

    SAINT-GENIS-POUILLY, France, March 06, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” ...

    author_avatar
    NASDAQ Market News

    Innate Pharma presents new CD73 checkpoint inhibitor program

    Novel antibodies identified that block the CD73 immune checkpoint for cancer immunotherapy; Strengthens Innate's ...

    author_avatar
    NASDAQ Market News

    Avant Diagnostics to Present at Upcoming Investor Conferences

    SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 31, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. ...

    author_avatar
    NASDAQ Market News